The increasingly popular class of therapies known as GLP-1 receptor agonists are revolutionizing diabetes management , but the delivery method is shifting to a key consideration . Traditionally , these beneficial medications were available solely in capsule form. However, new patches are now becoming accessible , leading to many patients to questio